Skip to main content
Premium Trial:

Request an Annual Quote

Canopy Biosciences Gene Expression Analysis Service

Canopy Biosciences has launched a service for high-throughput gene-expression analysis. Based on the NanoString nCounter platform, the service works with a large array of sample types, including formalin-fixed paraffin-embedded tissue. Canopy has paired this service with genome editing capabilities enabled by its recent licensing of TUNR flexible gene editing technology from Washington University in St. Louis and Johns Hopkins University. The new service features a web-based ordering tool, through which researchers can choose one of NanoString's pre-made gene panels or design their own custom panel. Each panel enables the simultaneous measurement of over 700 genes, Canopy said.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.